MACM

March Altus Capital Management Portfolio holdings

AUM $16M
This Quarter Return
+10.88%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$12.9M
AUM Growth
+$12.9M
Cap. Flow
+$2.55M
Cap. Flow %
19.73%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
3
Reduced
1
Closed
2

Top Buys

1
ACAD icon
Acadia Pharmaceuticals
ACAD
$1.99M
2
JNJ icon
Johnson & Johnson
JNJ
$1.58M
3
ALGN icon
Align Technology
ALGN
$963K
4
EW icon
Edwards Lifesciences
EW
$116K

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$826K
2
ATHN
Athenahealth, Inc.
ATHN
$680K
3
DXCM icon
DexCom
DXCM
$583K

Sector Composition

1 Healthcare 89.33%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACAD icon
1
Acadia Pharmaceuticals
ACAD
$4.38B
$2.69M 20.75%
82,723
+61,171
+284% +$1.99M
LLY icon
2
Eli Lilly
LLY
$657B
$2.11M 16.32%
26,810
– –
EW icon
3
Edwards Lifesciences
EW
$47.8B
$1.86M 14.35%
18,611
+1,168
+7% +$116K
JNJ icon
4
Johnson & Johnson
JNJ
$427B
$1.58M 12.19%
+13,000
New +$1.58M
ALGN icon
5
Align Technology
ALGN
$10.3B
$1.4M 10.78%
17,319
+11,953
+223% +$963K
PETX
6
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.38M 10.67%
218,515
– –
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$1M 7.76%
8,599
– –
DXCM icon
8
DexCom
DXCM
$29.5B
$928K 7.17%
11,700
-7,346
-39% -$583K
REGN icon
9
Regeneron Pharmaceuticals
REGN
$61.5B
– –
-2,291
Closed -$826K
ATHN
10
DELISTED
Athenahealth, Inc.
ATHN
– –
-4,900
Closed -$680K